Ennio Lubrano

Professor Ennio Lubrano is Full Professor of Rheumatology at the Department of Medicine and Health Sciences of the University of Molise, Campobasso, Italy and Guest Professor at the Department of Rheumatology of the Catholic University of Leuven (KU Leuven), Belgium. He is the Director of Academic Internal Medicine and Rheumatology Unit, NHS, Italy.
Main research interests include clinical research on outcome measures, imaging, and biomarkers in all spondyloarthritis including Psoriatic Arthritis.
Professor Lubrano is the Vice-President of the Italian Society for Rheumatology and is member of various scientific institutions including the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) in which is a Steering Committee Member, the Assessment of Spondyloarthritis International Society (ASAS).
He has authored or co-authored 237 publications, H-index 38, for several peer-reviewed journals, and acted as a reviewer for a large number of international journals.

Wiebke Sondermann

Wiebke Sondermann is a chief senior physician and Assistant Professor at the Department of Dermatology, University Hospital Essen, Germany. She graduated from the medical school of the University of Münster and trained in Dermatology at the University of Essen, Germany. Wiebke Sondermann has more than 12 years’ clinical experience as a dermatologist and has been running the general outpatient clinic and the psoriasis unit for many years. Her scientific focus is on inflammatory dermatoses with a special interest in mental health in psoriasis. She is the principal investigator of a translational scientific working group and has been widely published in medical journals. Sondermann‘s habilitation thesis was on “Improving the reality of care for psoriasis patients”. Currently she is the principal investigator of a project investigating the influence of treatment-related expectations in psoriasis patients in the context of a collaborative research centre funded by the German Research Foundation (DFG).

Curdin Conrad

Dr. Curdin Conrad is Professor of Dermatology at Lausanne University Hospital in Switzerland. He received his MD training at the University of Zurich, where he also participated at the Postgraduate Course of Experimental Medicine and Biology. After his training in Dermatology, he was research fellow at MD Anderson Cancer Center in Houston, Texas.

Dr. Conrad has a strong interest – from basic science to translational research and the clinic – in inflammatory skin diseases, adaptive and innate immunity, and targeted immunotherapies. He has fundamentally contributed to today’s understanding of the pathogenesis of psoriasis and has received several scientific awards for his basic and translational research. Over the years, Dr Conrad has actively been involved in the teaching of evidence-based clinical and scientific dermatology and immunology.

He serves as an external scientific expert for several international societies and foundations. Dr. Conrad is an elected councilor of the International Psoriasis Council (IPC) and, as Secretary-Treasurer, member of the executive committee of the European Society for Dermatological Research (ESDR).

Silvia Fernandez Barrio

Professionally, Silvia worked as a radio and TV journalist in Argentina from 1979 until 2000. At the age of 18, she was diagnosed with psoriasis. When a major psoriasis flare-up in 2004 left her unable to afford her new medication, Silvia took the initiative to found AEPSO – the first and only psoriasis patient organization in Argentina. Besides her role as President in AEPSO, Silvia is also the President and founder of IFPA’s regional member, LATINAPSO / the Latin-American Network of Psoriasis.

Kristina Callis Duffin

Kristina Callis Duffin, MD, MS is Professor and Chair of the Department of Dermatology at the University of Utah. She is an internationally recognized expert in psoriasis and has led over 60 clinical trials and observational studies in psoriasis and other skin diseases. She is the past Vice-Chair of the National Psoriasis Foundation Medical Board and Past President of GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis).

Laura Coates

Dr. Coates provides the rheumatological voice to this multidisciplinary committee. Dr. Coates is a Senior Research Fellow at the National Institute for Health and Care Research in Oxford, England. Her research is clinical and focuses on psoriatic arthritis and the spondyloarthritides including early diagnosis of PsA, development of PsA specific and validated outcome measures, optimal treatment pathways and strategies in PsA.

Julia Huang

Dr. Huang holds the position of Associate Professor in the Department of Dermatology at Chang Gung Memorial Hospital and Chang Gung University in Taiwan. In addition to her role as Director and Spokeswoman of the Taiwanese Dermatological Association, she has contributed to the psoriasis and urticaria guidelines committee of the same organization. Presently, Dr. Huang serves as the Executive Director of the Taiwanese Association for Psoriasis and Skin Immunology. Her extensive research work includes conducting several global clinical trials in phases II and III, focusing on conditions such as psoriasis, psoriatic arthritis, atopic dermatitis, and urticaria. Moreover, she is a prolific author with numerous articles on psoriasis and atopic dermatitis published in Pubmed.

Bruce Strober

Dr. Strober earned both his medical and his doctorate degrees from Columbia University in New York, New York. He subsequently completed his residency in dermatology in the Department of Dermatology, New York University School of Medicine in New York, New York. He is board certified by the American Board of Dermatology and a Fellow in the American Academy of Dermatology.

Dr. Strober is Clinical Professor of Dermatology at Yale University School of Medicine. He is currently the editor in Chief of the Journal of Psoriasis and Psoriatic Arthritis, Vice President and President-elect on the Board of the International Psoriasis Council and Scientific Co-Director of the CorEvitas Psoriasis Registry.

His primary clinical focus is the treatment of difficult-to-treat inflammatory diseases of the skin, such as psoriasis, atopic dermatitis and hidradenitis suppurativa.

Adam Reich

Prof. Adam Reich is the head of the Department of Dermatology, University of Rzeszow, Poland, Director of the Institute of Medical Sciences, University of Rzeszow, Regional Consultant for Dermatology and Venereology of Subcarpatian Voivodship, Secretary General of the Polish Dermatological Society, and the Vice-Chairman of the “Youth Forum” Section of the Polish Dermatological Society.

He is also a Chief-Editor of “Forum Dermatologicum”, and Section Editor for Journal of the European Academy of Dermatology and Venereology (Section: Itch/Psychology), Dermatology and Therapy (Section: Pruritus), Biomed Research International. He is an author or co-author of more than 300 scientific papers and book chapters. He is also a member of a number of international scientific societies (EADV, IFSI, ESDR, ISD, ESDAP, AKP Juckreiz). His major scientific interest is focused on pruritus, especially measurement of itch, psychodermatology, psoriasis and autoimmune connective tissue disorders.

Oseme Etomi

Dr Oseme Etomi is a Consultant Rheumatologist and Obstetric Physician in South East London and works across 2 NHS trusts including Guy’s and St Thomas’ Hospital and the Queen Elizabeth Hospital in Woolwich.

Within the field of Obstetric Medicine, her main interest is looking after women with inflammatory diseases and immunosuppression in pregnancy. She runs a weekly inflammatory rheumatic disease and a weekly inflammatory bowel disease clinic in pregnancy, alongside her Rheumatology practice.

Oseme has published abstracts and papers on Inflammatory Rheumatic Disease in pregnancy. In 2018 she was awarded the best oral presentation at the international Society of Obstetric Medicine for her work in this field. She was also instrumental in setting up the British Society of Rheumatology Specialist Interest Group in Pregnancy in 2019. She sits on the advisory board for the Biologics in Rheumatoid arthritis Pregnancy (BiRAP) group and is on the committee for the development of British Society of Dermatology guidelines for the use of Biologics in Pregnancy. Oseme was one of the organisers of the highly successful 12th Rheumapreg Symposium in September 2023 in London.

Her other interests include work on diversity, inclusion and wellbeing. She is the lead for trainee wellbeing in O&G at GSTT. A role she is extremely passionate about.

Siew Eng Choon

Siew Eng Choon is a senior consultant dermatologist at Hospital Sultanah Aminah, Johor Bahru, Malaysia and an Associate Professor at Clinical School Johor Bahru, Jeffrey Cheah School of Medicine and Health Sciences, Monash University, Malaysia. She is a foundation member of the Asian Academy of Dermatology and Venereology, an active member of the Malaysian Society of Dermatology, and a member of the Malaysian Medical Association. Dr. Choon is a Malaysian Skin Foundation trustee and chairs the research committee. She is a key project team leader for the Core Outcome Measures for Pustular Psoriasis and Associated Systemic Symptoms (COMPPASS) and a member of the Council for International Organizations of Medical Sciences – Severe Cutaneous Adverse Reactions of Drugs (CIOMS-SCAR) expert working group. Her research interests include chronic inflammatory skin diseases, namely atopic dermatitis, psoriasis, particularly pustular psoriasis, hidradenitis suppurativa, and cutaneous adverse drug reactions. Dr. Choon is a Board Member of the International Psoriasis Council (IPC) and an advisor of the Psoriasis Association of Johor, Malaysia. She is currently an associate editor of Experimental Dermatology.

Ulrich Mrowietz

Ulrich Mrowietz is Professor of Dermatology and founder of the Psoriasis Center at the Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. His main research areas in psoriasis include management strategies, drug development, and basic research. The Psoriasis Center is part of the Comprehensive Center for Inflammation Medicine (CCIM) at the Kiel Campus.

Professor Mrowietz is author or co-author of more than 400 peer-reviewed publications listed in the Medline database and numerous other publications in the field. His h-Index is >67. In addition, he is author of chapters in numerous psoriasis textbooks, including Braun-Falco’s Dermatology and Venerology.

From 2004 to 2019, Professor Mrowietz was Editor-in-Chief of Archives of Dermatological Research. He is a former member of the Executive Board of the German Dermatological Society, a councillor of the International Psoriasis Council, a member of the scientific advisory board of the German Psoriasis Association, a member of the Clusters of Excellence “Inflammation at Interfaces” and “Precision Medicine in Chronic Inflammation”, and of numerous dermatological societies. Professor Mrowietz was President of the 6th World Psoriasis and Psoriatic Arthritis Conference in July 2021 in Stockholm, Sweden, and is vice-president of the 7th in 2024.

Ingvar Ingvarsson

Ingvar was diagnosed with psoriasis when he was 23 and has had both ups and downs with the disease since then. During difficult times, he could depend on the valuable support of Spoex volunteers. When his psoriasis had improved and he was invited to join Spoex’ Board a few years later, Ingvar thus gladly accepted the invitation. Between 2014 and 2018, Ingvar was the organization’s Chairman. Being able to give something back to society and helping others is something he sees as a privilege. Professionally, Ingvar works as an IT technical solutions specialist.

Kathleen Gallant

Kathleen chairs the IFPA Task Force on Noncommunicable Diseases (NCDs), working on global psoriasis advocacy with the World Health Organization and United Nations agencies. She lives in Pittsburgh, Pennsylvania and serves as ex-officio to the United States’ National Psoriasis Foundation Board of Directors. Kathleen holds a Master’s degree in Public Administration / Nonprofit Management from the University of Pittsburgh Graduate School of Public and International Affairs.

Mark Lebwohl

Dr. Mark Lebwohl is Dean for Clinical Therapeutics and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai. He is a past President of the American Academy of Dermatology and Chairman Emeritus of the Medical Board of the National Psoriasis Foundation. He has published over 700 peer-reviewed articles and is editor of Treatment of Skin Disease which is now in its 6th edition and is published in English, Chinese, Polish, Portuguese, and Spanish. He is the founding editor of Psoriasis Forum and of the Journal of Psoriasis and Psoriatic Arthritis. He is editor of the Dermatology Section of Scientific American Medicine, and co-Editor-in-Chief of Skin, the Journal of Cutaneous Medicine.

Mohammad Samiul Huq

Professor MD Mohammad Samiul Huq is a 1980 medical graduate from Mymensingh Medical College, Bangladesh. He completed a diploma in Dermatological Science and a Master’s in Dermatology, from the college of medicine under the University of Wales, Cardiff, UK. He then obtained his master’s in Public Health from North South University. Professor Huq has many national and international publications. He is the founder and president of the psoriasis awareness club Bangladesh, affiliated with the International Federation of Psoriasis Association and SPIN network. He is the chief coordinator of the psoriasis guideline committee in Bangladesh. Under his supervision, Psoriasis Awareness Club started as a one-stop psoriasis treatment and research centre, a unique centre of excellence for psoriasis patients. Psoriasis skilled development program for primary care personnel started under his guidance. He is nominated councillor of International Psoriasis council. His field of interest is how to improve the quality of life of psoriasis patients.

Rachel Sommer

PD Dr. Rachel Sommer and her research group investigate the health of people with inflammatory skin diseases, taking into account physical, psychological and social aspects. People-centered health care as demanded by the World Health Organization is the focus of her research.

Here, one research area is the development and validation of measurements to characterise subjective burdens such as sexual impairments and perceived stigmatisation, patient needs and treatment outcomes such as well-being and quality of life.

Her research group conducts epidemiological, clinical and healthcare services studies in which these measurements are used nationally and internationally.

Another focus is the development and evaluation of interventions aiming to strengthen people-centred care and the (mental) health and well-being of people with visible chronic skin diseases.

Since September 2016, PD Dr. Rachel Sommer has been working as a researcher at the Institute for Health Services Research in Dermatology and the Nursing Professions (IVDP) at the University Medical Center Hamburg-Eppendorf (UKE). In 2015, she completed her PhD at the Department for Medical Psychology at the UKE on the quality of life in rare pediatric diseases. In 2021, she completed her habilitation (assistant professorship) in health services research. At the IVDP, she leads the research group "People-Centered Health Care".

Jörg Prinz

Prof. Dr. Jörg Christoph Prinz, MD, is affiliated with the Department of Dermatology and Allergy at the University Hospital of Ludwig-Maximilian-University in Munich, Germany. Graduating with a medical degree from the University of Innsbruck in 1983, he pursued further training in internal medicine at the University clinics of Freiburg before embarking on five years of basic immunology research as a postdoctoral fellow at the Institute for Immunology of the LMU in Munich.
In 1990, Prof. Prinz joined the Department for Dermatology and Allergy at the Ludwig-Maximilian-University, where he established the Research Group for Immunopathology. He obtained specialist qualifications in dermatology and venerology in 1995 and in allergology in 1996, eventually ascending to the position of Full Professor of Dermatology and Venerology in 2001.
Prof. Prinz's clinical and research interests predominantly center around psoriasis. Notably, he administered the first biologic therapy with antibodies against T-cells in psoriasis in 1991. His subsequent experimental research has focused on unraveling the T-cell mediated immunopathogenesis of psoriasis and identifying the target cells and autoantigens of the pathogenic psoriatic autoimmune response.
Among his seminal contributions is the discovery that psoriasis is underpinned by an autoimmune response of CD8+ T cells against melanocytes, substantiated by clonal T cell expansions. Prof. Prinz's work elucidated the role of the main psoriasis risk gene, HLA-C*06:02, in autoantigen presentation and proposed the potential influence of environmental antigens in sustaining the autoimmune response.
In addition to his research endeavors, Prof. Prinz established a psoriasis outpatient clinic and actively participated in numerous clinical trials of psoriasis therapy with biologics. His overarching objective has always been to furnish psoriasis patients with safe and effective therapies tailored to their individual circumstances.
Furthermore, Prof. Prinz has had the privilege of serving as the Scientific Chairman and President of the "2nd World Psoriasis and Psoriatic Arthritis Conference," organized by IFPA in 2009 in Stockholm.

Vinod Chandran

Vinod Chandran MBBS, MD, DM, PhD, FRCPC, a rheumatologist, is a clinician-scientist at the Krembil Research Institute, University Health Network, and an Associate Professor of Medicine & Laboratory Medicine and Pathobiology at the University of Toronto. He is an expert in psoriatic arthritis and directs the Psoriatic Disease Program at the Schroeder Arthritis Institute. His translational research program is focused on developing biomarker-based diagnostic and prognostic tools for psoriatic arthritis, with support by grants from the Canadian Institutes of Health Research, the National Psoriasis Foundation, the Arthritis Society, and the Krembil Foundation. He has published more than 200 papers. He is a member of the board of directors of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis and co-chairs its research committee.